Metropolitan Life Insurance Company (MetLife)’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,600	Closed	-$509K	–	2644
2020 Q1	$509K	Hold	10,600	–	–	0.01%	1037
2019 Q4	$497K	Hold	10,600	–	–	0.01%	1327
2019 Q3	$251K	Buy	10,600 +4,037	+62%	+$120K	﹤0.01%	1725
2019 Q2	$197K	Buy	6,563 +1,059	+19%	+$24.3K	﹤0.01%	1897
2019 Q1	$123K	Hold	5,504	–	–	﹤0.01%	2198
2018 Q4	$100K	Buy	+5,504	New	+$86.4K	﹤0.01%	2267
2017 Q3	–	Sell	-8,878	Closed	-$166K	–	2563
2017 Q2	$166K	Buy	+8,878	New	+$200K	﹤0.01%	2447

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s RARX Position: Q2 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 10,600 shares — an estimated $509K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RARX in Q2 2017 and held it in 7 quarters. The position peaked at $509K in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Metropolitan Life Insurance Company (MetLife) reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 10,600 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $509K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 7 quarters.
Metropolitan Life Insurance Company (MetLife)'s Ra Pharmaceuticals, Inc. Common Stock position peaked at $509K in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2020, filed 14 Aug 2020.